About Part 2

RCGP SMU PART 2
PART TWO is aimed at those wishing to become Practitioners with a Special Clinical Interest. It is expected that candidates will have completed the Part One Certificate and have an ongoing case load working with substance misusers.

Friday 5 November 2010

Part 2 2010 Results

Please find below the Part 2 results.
I am sorry for the long wait.
If your name is not on the list your folder is still being review.
Again I am sorry for the long delay.
You shall be receiving your certificate in the post soon.
¬Enrique

Dr Forida Abdullah
Dr Rashid Ahmad
Dr Rohaila Noshad Ahmed
Dr Muhammad Tanveer Alam
Miss Elizabeth Albertina
Dr Muhammad Zubair Ali
Dr Haseeb Amjad
Dr Richard Aw
Mrs Amelia Bailey
Miss Thembeka Bana
Mrs Claire Barber
Dr Laurent Bare
Dr Richard Donovan Barker
Mrs Sandra Elaine Barton
Dr Saheel Hussain Batt
Dr Elizabeth Marie Belham
Dr Victoria Bentley
Dr Arnold Berger
Dr Peter Billingsley
Dr Christopher Mark Binns
Dr Ducan Edward Blake
Dr Marija Bogdanovska-Marinova
Dr Hari Mohan Bonthala
Mr James Boyd
Dr Harriet Bradley
Mrs Jayne Donna Bridge
Miss Rebecca Brown
Dr Jennifer Mary Calvert
Miss Abioseh (Abby) Campbell
Miss Jennifer Carr
Dr David John Cavanagh
Miss Missbah Chaudhry
Dr Nasimul Choudhury
Ms Emma Coffield
Mr Anthony Paul Cosco
Dr Lindsey Crockett
Dr John Paul Culling
Miss Emma Dalwood
Dr Ellora Das
Dr Louise Davis
Miss Jennifer Dawson
Dr Theresa Jemima Murphy De Souza
Dr Samuel Dearman
Dr Sunila Dhaduvai
Ms Christine Dodd
Dr John A Ellerton
Miss Emily Rachel Fisher
Dr John Neil Fisher
Dr Neil Antony Forsdyke
Miss Lorraine Freemantle
Mr Gordon Garrick
Mr James Gasson
Mr Shawn Gaywood
Dr Ajaya Ghosh
Mrs Karen Gilliver
Dr Elise Godfrey
Dr Laimonas Goncaras
Dr Ugandrie Govender
Dr Christine Greenshaw
Dr Rachel Grenfell
Mr Hassan Hajat
Miss Catherine Hardy Elizabeth
Mrs Julie Harrington
Ms Kate Mary Harrison
Miss Rebecca Hayden
Mrs Joanne Hayward
Miss Tracey Hegarty
Dr Chandrika Hirani
Miss Michelle Hodkinson
Mrs Coryn Hudson
Dr Richard Ibrahim
Miss Paula Irvine
Dr Ashrafi Jabin
Dr Sushmita Kakati
Dr Sharan Kaur
Dr Muhammad Akbar Khan
Dr Peter Klesse
Dr Kyle Knox
Dr Juergen Kraemer
Miss Adeyinka Kumuyi
Dr Andreas G Lehmann
Dr Martin Lindsay
Mr Michael John Line
Mr William John Lloyd
Miss Tabitha Love
Dr Alyson Macpherson
Mrs Sara Malone
Dr Maurice Mann
Miss Lisa McGuinness
Miss Kerry Louise McKay
Dr Nkwayep Lawou Mpafe
Dr Melanie Fiona Munro
Dr Jan Musil
Miss Melissa Nash
Dr Joanna Helen Newell
Miss Mbilitam Ngozi
Dr Margus Noormets
Miss Jacqueline O'Brien
Dr Abdi-llah Abucar Osman
Mrs Amanda Plater
Mrs Jacqui Prescott
Mrs Susan Puckey
Mr Martin Richardson
Dr Jonathan Ring
Dr David James Robertson
Dr Ibraham Ademola Salau
Dr Mita Sau
Dr Heather Wynne Scott
Mr David Sharpe
Ms Stella Simpson
Mr Jacob Skaria
Mrs Wendy Smith
Miss Michelle Louise Smith
Mrs Rooksana Sobhee
Dr Ravinder Nath Sood
Dr Ann-Marie Stewart
Dr Malcolm Stone
Dr Mark Struthers
Miss Barbara Sullivan
Dr Dax Tennant
Dr Tony Thekkekkara
Dr Geraint Huw Thomas
Ms Louise Tiffen
Miss Lorraine Diane Tomlinson
Dr Tuan Tran
Mrs Wendy Tubby
Dr Michael Uti
Mr Ravi Vaitha
Dr Nanthakumar Vaithilingam
Dr Roya Vaziri
Miss Sue Waldron
Mrs Tracey Jane Walker
Dr Ian Wall
Dr Pamela Walters
Dr David William Earl Ward
Miss Laura Jane Ward
Mrs Kay Marie Whinfrey
Dr Deborah Kathleen Wilmot
Mrs Claire Wood
Mr Matthew William Young
Dr Jolly Zachariah
Dr Ashraf Zaman

Tuesday 20 July 2010

Change of Address

Please note that the SMU office will be changing their address.
From the 13th of August our new address will be:
1 Bow Churchyard, London EC4M 9DQ.

Thursday 11 March 2010

Naltrexone for the management of opioid dependence

Naltrexone is recommended as a treatment option for people who have been opioid dependent but who have stopped using opioids, and who are highly motivated to stay free from the drugs in an abstinence programme.

It should only be given to people who have been told about the problems associated with treatment, and with proper supervision. Treatment with naltrexone should be given as part of a support programme to help the person manage their opioid dependence.

Healthcare professionals should regularly review how well naltrexone is working to help people stay off opioids. If there is evidence that the person has been using the drugs again then healthcare professionals should consider stopping naltrexone treatment.

Click here for the full artical.

Drug misuse - methadone and buprenorphine

Methadone and buprenorphine (given as a tablet or a liquid) are recommended as treatment options for people who are opioid dependent.

A decision about which is the better treatment should be made on an individual basis, in consultation with the person, taking into account the possible benefits and risks of each treatment for that particular person. If both drugs are likely to have the same benefits and risks, methadone should be given as the first choice.

Different people will need different doses of methadone or buprenorphine. People should take methadone or buprenorphine daily in the presence of their doctor, nurse or community pharmacist for at least the first 3 months of treatment and until they are able to continue their treatment correctly without supervision.

Treatment with methadone or buprenorphine should be given as part of a support programme to help the person manage their opioid dependence


Click Here to be taken to the full artical.

Presentations from the RMC

Please find below the links to the Presentations from the various Regional Master Classes.
Nat's Presentation
How To Read an Academic Paper
Linda's Manchester RMC presentation
Gordon's Presentation
Steve's Presentation

Friday 26 February 2010

Presentation from the RMC

After the final Regional Master Class on the 5th of March I will post links here for the Presentations.